Medical Care
Global Oral Antihypertensive Drug Market Research Report 2025
- Mar 11, 25
- ID: 77648
- Pages: 87
- Figures: 82
- Views: 16
The global market for Oral Antihypertensive Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Oral Antihypertensive Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Antihypertensive Drug.
The Oral Antihypertensive Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Antihypertensive Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Antihypertensive Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Pfizer
Johnson & Johnson
Sanofi
Lupin
Ranbaxy Laboratories
Merck
Astra Zeneca
Daiichi Sankyo
Takeda
Actelion
United Therapeutics
Segment by Type
Diuretics
β-blockers
Calcium Channel Blockers
Renin-angiotensin System Inhibitors
Segment by Application
Online Pharmacy
Offline Pharmacy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Antihypertensive Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Oral Antihypertensive Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Antihypertensive Drug.
The Oral Antihypertensive Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Antihypertensive Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Antihypertensive Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Pfizer
Johnson & Johnson
Sanofi
Lupin
Ranbaxy Laboratories
Merck
Astra Zeneca
Daiichi Sankyo
Takeda
Actelion
United Therapeutics
Segment by Type
Diuretics
β-blockers
Calcium Channel Blockers
Renin-angiotensin System Inhibitors
Segment by Application
Online Pharmacy
Offline Pharmacy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Antihypertensive Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Antihypertensive Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Diuretics
1.2.3 β-blockers
1.2.4 Calcium Channel Blockers
1.2.5 Renin-angiotensin System Inhibitors
1.3 Market by Application
1.3.1 Global Oral Antihypertensive Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Online Pharmacy
1.3.3 Offline Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Antihypertensive Drug Market Perspective (2020-2031)
2.2 Global Oral Antihypertensive Drug Growth Trends by Region
2.2.1 Global Oral Antihypertensive Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Oral Antihypertensive Drug Historic Market Size by Region (2020-2025)
2.2.3 Oral Antihypertensive Drug Forecasted Market Size by Region (2026-2031)
2.3 Oral Antihypertensive Drug Market Dynamics
2.3.1 Oral Antihypertensive Drug Industry Trends
2.3.2 Oral Antihypertensive Drug Market Drivers
2.3.3 Oral Antihypertensive Drug Market Challenges
2.3.4 Oral Antihypertensive Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Antihypertensive Drug Players by Revenue
3.1.1 Global Top Oral Antihypertensive Drug Players by Revenue (2020-2025)
3.1.2 Global Oral Antihypertensive Drug Revenue Market Share by Players (2020-2025)
3.2 Global Oral Antihypertensive Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oral Antihypertensive Drug Revenue
3.4 Global Oral Antihypertensive Drug Market Concentration Ratio
3.4.1 Global Oral Antihypertensive Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Antihypertensive Drug Revenue in 2024
3.5 Global Key Players of Oral Antihypertensive Drug Head office and Area Served
3.6 Global Key Players of Oral Antihypertensive Drug, Product and Application
3.7 Global Key Players of Oral Antihypertensive Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Antihypertensive Drug Breakdown Data by Type
4.1 Global Oral Antihypertensive Drug Historic Market Size by Type (2020-2025)
4.2 Global Oral Antihypertensive Drug Forecasted Market Size by Type (2026-2031)
5 Oral Antihypertensive Drug Breakdown Data by Application
5.1 Global Oral Antihypertensive Drug Historic Market Size by Application (2020-2025)
5.2 Global Oral Antihypertensive Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Oral Antihypertensive Drug Market Size (2020-2031)
6.2 North America Oral Antihypertensive Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Oral Antihypertensive Drug Market Size by Country (2020-2025)
6.4 North America Oral Antihypertensive Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oral Antihypertensive Drug Market Size (2020-2031)
7.2 Europe Oral Antihypertensive Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Oral Antihypertensive Drug Market Size by Country (2020-2025)
7.4 Europe Oral Antihypertensive Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral Antihypertensive Drug Market Size (2020-2031)
8.2 Asia-Pacific Oral Antihypertensive Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Oral Antihypertensive Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Oral Antihypertensive Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oral Antihypertensive Drug Market Size (2020-2031)
9.2 Latin America Oral Antihypertensive Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Oral Antihypertensive Drug Market Size by Country (2020-2025)
9.4 Latin America Oral Antihypertensive Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Antihypertensive Drug Market Size (2020-2031)
10.2 Middle East & Africa Oral Antihypertensive Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Oral Antihypertensive Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Oral Antihypertensive Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Oral Antihypertensive Drug Introduction
11.1.4 Novartis Revenue in Oral Antihypertensive Drug Business (2020-2025)
11.1.5 Novartis Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Oral Antihypertensive Drug Introduction
11.2.4 Pfizer Revenue in Oral Antihypertensive Drug Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Oral Antihypertensive Drug Introduction
11.3.4 Johnson & Johnson Revenue in Oral Antihypertensive Drug Business (2020-2025)
11.3.5 Johnson & Johnson Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Oral Antihypertensive Drug Introduction
11.4.4 Sanofi Revenue in Oral Antihypertensive Drug Business (2020-2025)
11.4.5 Sanofi Recent Development
11.5 Lupin
11.5.1 Lupin Company Details
11.5.2 Lupin Business Overview
11.5.3 Lupin Oral Antihypertensive Drug Introduction
11.5.4 Lupin Revenue in Oral Antihypertensive Drug Business (2020-2025)
11.5.5 Lupin Recent Development
11.6 Ranbaxy Laboratories
11.6.1 Ranbaxy Laboratories Company Details
11.6.2 Ranbaxy Laboratories Business Overview
11.6.3 Ranbaxy Laboratories Oral Antihypertensive Drug Introduction
11.6.4 Ranbaxy Laboratories Revenue in Oral Antihypertensive Drug Business (2020-2025)
11.6.5 Ranbaxy Laboratories Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Oral Antihypertensive Drug Introduction
11.7.4 Merck Revenue in Oral Antihypertensive Drug Business (2020-2025)
11.7.5 Merck Recent Development
11.8 Astra Zeneca
11.8.1 Astra Zeneca Company Details
11.8.2 Astra Zeneca Business Overview
11.8.3 Astra Zeneca Oral Antihypertensive Drug Introduction
11.8.4 Astra Zeneca Revenue in Oral Antihypertensive Drug Business (2020-2025)
11.8.5 Astra Zeneca Recent Development
11.9 Daiichi Sankyo
11.9.1 Daiichi Sankyo Company Details
11.9.2 Daiichi Sankyo Business Overview
11.9.3 Daiichi Sankyo Oral Antihypertensive Drug Introduction
11.9.4 Daiichi Sankyo Revenue in Oral Antihypertensive Drug Business (2020-2025)
11.9.5 Daiichi Sankyo Recent Development
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Oral Antihypertensive Drug Introduction
11.10.4 Takeda Revenue in Oral Antihypertensive Drug Business (2020-2025)
11.10.5 Takeda Recent Development
11.11 Actelion
11.11.1 Actelion Company Details
11.11.2 Actelion Business Overview
11.11.3 Actelion Oral Antihypertensive Drug Introduction
11.11.4 Actelion Revenue in Oral Antihypertensive Drug Business (2020-2025)
11.11.5 Actelion Recent Development
11.12 United Therapeutics
11.12.1 United Therapeutics Company Details
11.12.2 United Therapeutics Business Overview
11.12.3 United Therapeutics Oral Antihypertensive Drug Introduction
11.12.4 United Therapeutics Revenue in Oral Antihypertensive Drug Business (2020-2025)
11.12.5 United Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Antihypertensive Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Diuretics
1.2.3 β-blockers
1.2.4 Calcium Channel Blockers
1.2.5 Renin-angiotensin System Inhibitors
1.3 Market by Application
1.3.1 Global Oral Antihypertensive Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Online Pharmacy
1.3.3 Offline Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Antihypertensive Drug Market Perspective (2020-2031)
2.2 Global Oral Antihypertensive Drug Growth Trends by Region
2.2.1 Global Oral Antihypertensive Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Oral Antihypertensive Drug Historic Market Size by Region (2020-2025)
2.2.3 Oral Antihypertensive Drug Forecasted Market Size by Region (2026-2031)
2.3 Oral Antihypertensive Drug Market Dynamics
2.3.1 Oral Antihypertensive Drug Industry Trends
2.3.2 Oral Antihypertensive Drug Market Drivers
2.3.3 Oral Antihypertensive Drug Market Challenges
2.3.4 Oral Antihypertensive Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Antihypertensive Drug Players by Revenue
3.1.1 Global Top Oral Antihypertensive Drug Players by Revenue (2020-2025)
3.1.2 Global Oral Antihypertensive Drug Revenue Market Share by Players (2020-2025)
3.2 Global Oral Antihypertensive Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oral Antihypertensive Drug Revenue
3.4 Global Oral Antihypertensive Drug Market Concentration Ratio
3.4.1 Global Oral Antihypertensive Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Antihypertensive Drug Revenue in 2024
3.5 Global Key Players of Oral Antihypertensive Drug Head office and Area Served
3.6 Global Key Players of Oral Antihypertensive Drug, Product and Application
3.7 Global Key Players of Oral Antihypertensive Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Antihypertensive Drug Breakdown Data by Type
4.1 Global Oral Antihypertensive Drug Historic Market Size by Type (2020-2025)
4.2 Global Oral Antihypertensive Drug Forecasted Market Size by Type (2026-2031)
5 Oral Antihypertensive Drug Breakdown Data by Application
5.1 Global Oral Antihypertensive Drug Historic Market Size by Application (2020-2025)
5.2 Global Oral Antihypertensive Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Oral Antihypertensive Drug Market Size (2020-2031)
6.2 North America Oral Antihypertensive Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Oral Antihypertensive Drug Market Size by Country (2020-2025)
6.4 North America Oral Antihypertensive Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oral Antihypertensive Drug Market Size (2020-2031)
7.2 Europe Oral Antihypertensive Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Oral Antihypertensive Drug Market Size by Country (2020-2025)
7.4 Europe Oral Antihypertensive Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral Antihypertensive Drug Market Size (2020-2031)
8.2 Asia-Pacific Oral Antihypertensive Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Oral Antihypertensive Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Oral Antihypertensive Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oral Antihypertensive Drug Market Size (2020-2031)
9.2 Latin America Oral Antihypertensive Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Oral Antihypertensive Drug Market Size by Country (2020-2025)
9.4 Latin America Oral Antihypertensive Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Antihypertensive Drug Market Size (2020-2031)
10.2 Middle East & Africa Oral Antihypertensive Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Oral Antihypertensive Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Oral Antihypertensive Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Oral Antihypertensive Drug Introduction
11.1.4 Novartis Revenue in Oral Antihypertensive Drug Business (2020-2025)
11.1.5 Novartis Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Oral Antihypertensive Drug Introduction
11.2.4 Pfizer Revenue in Oral Antihypertensive Drug Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Oral Antihypertensive Drug Introduction
11.3.4 Johnson & Johnson Revenue in Oral Antihypertensive Drug Business (2020-2025)
11.3.5 Johnson & Johnson Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Oral Antihypertensive Drug Introduction
11.4.4 Sanofi Revenue in Oral Antihypertensive Drug Business (2020-2025)
11.4.5 Sanofi Recent Development
11.5 Lupin
11.5.1 Lupin Company Details
11.5.2 Lupin Business Overview
11.5.3 Lupin Oral Antihypertensive Drug Introduction
11.5.4 Lupin Revenue in Oral Antihypertensive Drug Business (2020-2025)
11.5.5 Lupin Recent Development
11.6 Ranbaxy Laboratories
11.6.1 Ranbaxy Laboratories Company Details
11.6.2 Ranbaxy Laboratories Business Overview
11.6.3 Ranbaxy Laboratories Oral Antihypertensive Drug Introduction
11.6.4 Ranbaxy Laboratories Revenue in Oral Antihypertensive Drug Business (2020-2025)
11.6.5 Ranbaxy Laboratories Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Oral Antihypertensive Drug Introduction
11.7.4 Merck Revenue in Oral Antihypertensive Drug Business (2020-2025)
11.7.5 Merck Recent Development
11.8 Astra Zeneca
11.8.1 Astra Zeneca Company Details
11.8.2 Astra Zeneca Business Overview
11.8.3 Astra Zeneca Oral Antihypertensive Drug Introduction
11.8.4 Astra Zeneca Revenue in Oral Antihypertensive Drug Business (2020-2025)
11.8.5 Astra Zeneca Recent Development
11.9 Daiichi Sankyo
11.9.1 Daiichi Sankyo Company Details
11.9.2 Daiichi Sankyo Business Overview
11.9.3 Daiichi Sankyo Oral Antihypertensive Drug Introduction
11.9.4 Daiichi Sankyo Revenue in Oral Antihypertensive Drug Business (2020-2025)
11.9.5 Daiichi Sankyo Recent Development
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Oral Antihypertensive Drug Introduction
11.10.4 Takeda Revenue in Oral Antihypertensive Drug Business (2020-2025)
11.10.5 Takeda Recent Development
11.11 Actelion
11.11.1 Actelion Company Details
11.11.2 Actelion Business Overview
11.11.3 Actelion Oral Antihypertensive Drug Introduction
11.11.4 Actelion Revenue in Oral Antihypertensive Drug Business (2020-2025)
11.11.5 Actelion Recent Development
11.12 United Therapeutics
11.12.1 United Therapeutics Company Details
11.12.2 United Therapeutics Business Overview
11.12.3 United Therapeutics Oral Antihypertensive Drug Introduction
11.12.4 United Therapeutics Revenue in Oral Antihypertensive Drug Business (2020-2025)
11.12.5 United Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Oral Antihypertensive Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Diuretics
Table 3. Key Players of β-blockers
Table 4. Key Players of Calcium Channel Blockers
Table 5. Key Players of Renin-angiotensin System Inhibitors
Table 6. Global Oral Antihypertensive Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Oral Antihypertensive Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Oral Antihypertensive Drug Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Oral Antihypertensive Drug Market Share by Region (2020-2025)
Table 10. Global Oral Antihypertensive Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Oral Antihypertensive Drug Market Share by Region (2026-2031)
Table 12. Oral Antihypertensive Drug Market Trends
Table 13. Oral Antihypertensive Drug Market Drivers
Table 14. Oral Antihypertensive Drug Market Challenges
Table 15. Oral Antihypertensive Drug Market Restraints
Table 16. Global Oral Antihypertensive Drug Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Oral Antihypertensive Drug Market Share by Players (2020-2025)
Table 18. Global Top Oral Antihypertensive Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antihypertensive Drug as of 2024)
Table 19. Ranking of Global Top Oral Antihypertensive Drug Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Oral Antihypertensive Drug Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Oral Antihypertensive Drug, Headquarters and Area Served
Table 22. Global Key Players of Oral Antihypertensive Drug, Product and Application
Table 23. Global Key Players of Oral Antihypertensive Drug, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Oral Antihypertensive Drug Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Oral Antihypertensive Drug Revenue Market Share by Type (2020-2025)
Table 27. Global Oral Antihypertensive Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Oral Antihypertensive Drug Revenue Market Share by Type (2026-2031)
Table 29. Global Oral Antihypertensive Drug Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Oral Antihypertensive Drug Revenue Market Share by Application (2020-2025)
Table 31. Global Oral Antihypertensive Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Oral Antihypertensive Drug Revenue Market Share by Application (2026-2031)
Table 33. North America Oral Antihypertensive Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Oral Antihypertensive Drug Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Oral Antihypertensive Drug Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Oral Antihypertensive Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Oral Antihypertensive Drug Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Oral Antihypertensive Drug Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Oral Antihypertensive Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Oral Antihypertensive Drug Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Oral Antihypertensive Drug Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Oral Antihypertensive Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Oral Antihypertensive Drug Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Oral Antihypertensive Drug Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Oral Antihypertensive Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Oral Antihypertensive Drug Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Oral Antihypertensive Drug Market Size by Country (2026-2031) & (US$ Million)
Table 48. Novartis Company Details
Table 49. Novartis Business Overview
Table 50. Novartis Oral Antihypertensive Drug Product
Table 51. Novartis Revenue in Oral Antihypertensive Drug Business (2020-2025) & (US$ Million)
Table 52. Novartis Recent Development
Table 53. Pfizer Company Details
Table 54. Pfizer Business Overview
Table 55. Pfizer Oral Antihypertensive Drug Product
Table 56. Pfizer Revenue in Oral Antihypertensive Drug Business (2020-2025) & (US$ Million)
Table 57. Pfizer Recent Development
Table 58. Johnson & Johnson Company Details
Table 59. Johnson & Johnson Business Overview
Table 60. Johnson & Johnson Oral Antihypertensive Drug Product
Table 61. Johnson & Johnson Revenue in Oral Antihypertensive Drug Business (2020-2025) & (US$ Million)
Table 62. Johnson & Johnson Recent Development
Table 63. Sanofi Company Details
Table 64. Sanofi Business Overview
Table 65. Sanofi Oral Antihypertensive Drug Product
Table 66. Sanofi Revenue in Oral Antihypertensive Drug Business (2020-2025) & (US$ Million)
Table 67. Sanofi Recent Development
Table 68. Lupin Company Details
Table 69. Lupin Business Overview
Table 70. Lupin Oral Antihypertensive Drug Product
Table 71. Lupin Revenue in Oral Antihypertensive Drug Business (2020-2025) & (US$ Million)
Table 72. Lupin Recent Development
Table 73. Ranbaxy Laboratories Company Details
Table 74. Ranbaxy Laboratories Business Overview
Table 75. Ranbaxy Laboratories Oral Antihypertensive Drug Product
Table 76. Ranbaxy Laboratories Revenue in Oral Antihypertensive Drug Business (2020-2025) & (US$ Million)
Table 77. Ranbaxy Laboratories Recent Development
Table 78. Merck Company Details
Table 79. Merck Business Overview
Table 80. Merck Oral Antihypertensive Drug Product
Table 81. Merck Revenue in Oral Antihypertensive Drug Business (2020-2025) & (US$ Million)
Table 82. Merck Recent Development
Table 83. Astra Zeneca Company Details
Table 84. Astra Zeneca Business Overview
Table 85. Astra Zeneca Oral Antihypertensive Drug Product
Table 86. Astra Zeneca Revenue in Oral Antihypertensive Drug Business (2020-2025) & (US$ Million)
Table 87. Astra Zeneca Recent Development
Table 88. Daiichi Sankyo Company Details
Table 89. Daiichi Sankyo Business Overview
Table 90. Daiichi Sankyo Oral Antihypertensive Drug Product
Table 91. Daiichi Sankyo Revenue in Oral Antihypertensive Drug Business (2020-2025) & (US$ Million)
Table 92. Daiichi Sankyo Recent Development
Table 93. Takeda Company Details
Table 94. Takeda Business Overview
Table 95. Takeda Oral Antihypertensive Drug Product
Table 96. Takeda Revenue in Oral Antihypertensive Drug Business (2020-2025) & (US$ Million)
Table 97. Takeda Recent Development
Table 98. Actelion Company Details
Table 99. Actelion Business Overview
Table 100. Actelion Oral Antihypertensive Drug Product
Table 101. Actelion Revenue in Oral Antihypertensive Drug Business (2020-2025) & (US$ Million)
Table 102. Actelion Recent Development
Table 103. United Therapeutics Company Details
Table 104. United Therapeutics Business Overview
Table 105. United Therapeutics Oral Antihypertensive Drug Product
Table 106. United Therapeutics Revenue in Oral Antihypertensive Drug Business (2020-2025) & (US$ Million)
Table 107. United Therapeutics Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Oral Antihypertensive Drug Picture
Figure 2. Global Oral Antihypertensive Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oral Antihypertensive Drug Market Share by Type: 2024 VS 2031
Figure 4. Diuretics Features
Figure 5. β-blockers Features
Figure 6. Calcium Channel Blockers Features
Figure 7. Renin-angiotensin System Inhibitors Features
Figure 8. Global Oral Antihypertensive Drug Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Oral Antihypertensive Drug Market Share by Application: 2024 VS 2031
Figure 10. Online Pharmacy Case Studies
Figure 11. Offline Pharmacy Case Studies
Figure 12. Oral Antihypertensive Drug Report Years Considered
Figure 13. Global Oral Antihypertensive Drug Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Oral Antihypertensive Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Oral Antihypertensive Drug Market Share by Region: 2024 VS 2031
Figure 16. Global Oral Antihypertensive Drug Market Share by Players in 2024
Figure 17. Global Top Oral Antihypertensive Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antihypertensive Drug as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Oral Antihypertensive Drug Revenue in 2024
Figure 19. North America Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Oral Antihypertensive Drug Market Share by Country (2020-2031)
Figure 21. United States Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Oral Antihypertensive Drug Market Share by Country (2020-2031)
Figure 25. Germany Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Oral Antihypertensive Drug Market Share by Region (2020-2031)
Figure 33. China Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Oral Antihypertensive Drug Market Share by Country (2020-2031)
Figure 41. Mexico Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Oral Antihypertensive Drug Market Share by Country (2020-2031)
Figure 45. Turkey Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Novartis Revenue Growth Rate in Oral Antihypertensive Drug Business (2020-2025)
Figure 49. Pfizer Revenue Growth Rate in Oral Antihypertensive Drug Business (2020-2025)
Figure 50. Johnson & Johnson Revenue Growth Rate in Oral Antihypertensive Drug Business (2020-2025)
Figure 51. Sanofi Revenue Growth Rate in Oral Antihypertensive Drug Business (2020-2025)
Figure 52. Lupin Revenue Growth Rate in Oral Antihypertensive Drug Business (2020-2025)
Figure 53. Ranbaxy Laboratories Revenue Growth Rate in Oral Antihypertensive Drug Business (2020-2025)
Figure 54. Merck Revenue Growth Rate in Oral Antihypertensive Drug Business (2020-2025)
Figure 55. Astra Zeneca Revenue Growth Rate in Oral Antihypertensive Drug Business (2020-2025)
Figure 56. Daiichi Sankyo Revenue Growth Rate in Oral Antihypertensive Drug Business (2020-2025)
Figure 57. Takeda Revenue Growth Rate in Oral Antihypertensive Drug Business (2020-2025)
Figure 58. Actelion Revenue Growth Rate in Oral Antihypertensive Drug Business (2020-2025)
Figure 59. United Therapeutics Revenue Growth Rate in Oral Antihypertensive Drug Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Oral Antihypertensive Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Diuretics
Table 3. Key Players of β-blockers
Table 4. Key Players of Calcium Channel Blockers
Table 5. Key Players of Renin-angiotensin System Inhibitors
Table 6. Global Oral Antihypertensive Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Oral Antihypertensive Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Oral Antihypertensive Drug Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Oral Antihypertensive Drug Market Share by Region (2020-2025)
Table 10. Global Oral Antihypertensive Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Oral Antihypertensive Drug Market Share by Region (2026-2031)
Table 12. Oral Antihypertensive Drug Market Trends
Table 13. Oral Antihypertensive Drug Market Drivers
Table 14. Oral Antihypertensive Drug Market Challenges
Table 15. Oral Antihypertensive Drug Market Restraints
Table 16. Global Oral Antihypertensive Drug Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Oral Antihypertensive Drug Market Share by Players (2020-2025)
Table 18. Global Top Oral Antihypertensive Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antihypertensive Drug as of 2024)
Table 19. Ranking of Global Top Oral Antihypertensive Drug Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Oral Antihypertensive Drug Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Oral Antihypertensive Drug, Headquarters and Area Served
Table 22. Global Key Players of Oral Antihypertensive Drug, Product and Application
Table 23. Global Key Players of Oral Antihypertensive Drug, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Oral Antihypertensive Drug Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Oral Antihypertensive Drug Revenue Market Share by Type (2020-2025)
Table 27. Global Oral Antihypertensive Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Oral Antihypertensive Drug Revenue Market Share by Type (2026-2031)
Table 29. Global Oral Antihypertensive Drug Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Oral Antihypertensive Drug Revenue Market Share by Application (2020-2025)
Table 31. Global Oral Antihypertensive Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Oral Antihypertensive Drug Revenue Market Share by Application (2026-2031)
Table 33. North America Oral Antihypertensive Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Oral Antihypertensive Drug Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Oral Antihypertensive Drug Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Oral Antihypertensive Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Oral Antihypertensive Drug Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Oral Antihypertensive Drug Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Oral Antihypertensive Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Oral Antihypertensive Drug Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Oral Antihypertensive Drug Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Oral Antihypertensive Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Oral Antihypertensive Drug Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Oral Antihypertensive Drug Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Oral Antihypertensive Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Oral Antihypertensive Drug Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Oral Antihypertensive Drug Market Size by Country (2026-2031) & (US$ Million)
Table 48. Novartis Company Details
Table 49. Novartis Business Overview
Table 50. Novartis Oral Antihypertensive Drug Product
Table 51. Novartis Revenue in Oral Antihypertensive Drug Business (2020-2025) & (US$ Million)
Table 52. Novartis Recent Development
Table 53. Pfizer Company Details
Table 54. Pfizer Business Overview
Table 55. Pfizer Oral Antihypertensive Drug Product
Table 56. Pfizer Revenue in Oral Antihypertensive Drug Business (2020-2025) & (US$ Million)
Table 57. Pfizer Recent Development
Table 58. Johnson & Johnson Company Details
Table 59. Johnson & Johnson Business Overview
Table 60. Johnson & Johnson Oral Antihypertensive Drug Product
Table 61. Johnson & Johnson Revenue in Oral Antihypertensive Drug Business (2020-2025) & (US$ Million)
Table 62. Johnson & Johnson Recent Development
Table 63. Sanofi Company Details
Table 64. Sanofi Business Overview
Table 65. Sanofi Oral Antihypertensive Drug Product
Table 66. Sanofi Revenue in Oral Antihypertensive Drug Business (2020-2025) & (US$ Million)
Table 67. Sanofi Recent Development
Table 68. Lupin Company Details
Table 69. Lupin Business Overview
Table 70. Lupin Oral Antihypertensive Drug Product
Table 71. Lupin Revenue in Oral Antihypertensive Drug Business (2020-2025) & (US$ Million)
Table 72. Lupin Recent Development
Table 73. Ranbaxy Laboratories Company Details
Table 74. Ranbaxy Laboratories Business Overview
Table 75. Ranbaxy Laboratories Oral Antihypertensive Drug Product
Table 76. Ranbaxy Laboratories Revenue in Oral Antihypertensive Drug Business (2020-2025) & (US$ Million)
Table 77. Ranbaxy Laboratories Recent Development
Table 78. Merck Company Details
Table 79. Merck Business Overview
Table 80. Merck Oral Antihypertensive Drug Product
Table 81. Merck Revenue in Oral Antihypertensive Drug Business (2020-2025) & (US$ Million)
Table 82. Merck Recent Development
Table 83. Astra Zeneca Company Details
Table 84. Astra Zeneca Business Overview
Table 85. Astra Zeneca Oral Antihypertensive Drug Product
Table 86. Astra Zeneca Revenue in Oral Antihypertensive Drug Business (2020-2025) & (US$ Million)
Table 87. Astra Zeneca Recent Development
Table 88. Daiichi Sankyo Company Details
Table 89. Daiichi Sankyo Business Overview
Table 90. Daiichi Sankyo Oral Antihypertensive Drug Product
Table 91. Daiichi Sankyo Revenue in Oral Antihypertensive Drug Business (2020-2025) & (US$ Million)
Table 92. Daiichi Sankyo Recent Development
Table 93. Takeda Company Details
Table 94. Takeda Business Overview
Table 95. Takeda Oral Antihypertensive Drug Product
Table 96. Takeda Revenue in Oral Antihypertensive Drug Business (2020-2025) & (US$ Million)
Table 97. Takeda Recent Development
Table 98. Actelion Company Details
Table 99. Actelion Business Overview
Table 100. Actelion Oral Antihypertensive Drug Product
Table 101. Actelion Revenue in Oral Antihypertensive Drug Business (2020-2025) & (US$ Million)
Table 102. Actelion Recent Development
Table 103. United Therapeutics Company Details
Table 104. United Therapeutics Business Overview
Table 105. United Therapeutics Oral Antihypertensive Drug Product
Table 106. United Therapeutics Revenue in Oral Antihypertensive Drug Business (2020-2025) & (US$ Million)
Table 107. United Therapeutics Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Oral Antihypertensive Drug Picture
Figure 2. Global Oral Antihypertensive Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oral Antihypertensive Drug Market Share by Type: 2024 VS 2031
Figure 4. Diuretics Features
Figure 5. β-blockers Features
Figure 6. Calcium Channel Blockers Features
Figure 7. Renin-angiotensin System Inhibitors Features
Figure 8. Global Oral Antihypertensive Drug Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Oral Antihypertensive Drug Market Share by Application: 2024 VS 2031
Figure 10. Online Pharmacy Case Studies
Figure 11. Offline Pharmacy Case Studies
Figure 12. Oral Antihypertensive Drug Report Years Considered
Figure 13. Global Oral Antihypertensive Drug Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Oral Antihypertensive Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Oral Antihypertensive Drug Market Share by Region: 2024 VS 2031
Figure 16. Global Oral Antihypertensive Drug Market Share by Players in 2024
Figure 17. Global Top Oral Antihypertensive Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antihypertensive Drug as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Oral Antihypertensive Drug Revenue in 2024
Figure 19. North America Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Oral Antihypertensive Drug Market Share by Country (2020-2031)
Figure 21. United States Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Oral Antihypertensive Drug Market Share by Country (2020-2031)
Figure 25. Germany Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Oral Antihypertensive Drug Market Share by Region (2020-2031)
Figure 33. China Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Oral Antihypertensive Drug Market Share by Country (2020-2031)
Figure 41. Mexico Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Oral Antihypertensive Drug Market Share by Country (2020-2031)
Figure 45. Turkey Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Oral Antihypertensive Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Novartis Revenue Growth Rate in Oral Antihypertensive Drug Business (2020-2025)
Figure 49. Pfizer Revenue Growth Rate in Oral Antihypertensive Drug Business (2020-2025)
Figure 50. Johnson & Johnson Revenue Growth Rate in Oral Antihypertensive Drug Business (2020-2025)
Figure 51. Sanofi Revenue Growth Rate in Oral Antihypertensive Drug Business (2020-2025)
Figure 52. Lupin Revenue Growth Rate in Oral Antihypertensive Drug Business (2020-2025)
Figure 53. Ranbaxy Laboratories Revenue Growth Rate in Oral Antihypertensive Drug Business (2020-2025)
Figure 54. Merck Revenue Growth Rate in Oral Antihypertensive Drug Business (2020-2025)
Figure 55. Astra Zeneca Revenue Growth Rate in Oral Antihypertensive Drug Business (2020-2025)
Figure 56. Daiichi Sankyo Revenue Growth Rate in Oral Antihypertensive Drug Business (2020-2025)
Figure 57. Takeda Revenue Growth Rate in Oral Antihypertensive Drug Business (2020-2025)
Figure 58. Actelion Revenue Growth Rate in Oral Antihypertensive Drug Business (2020-2025)
Figure 59. United Therapeutics Revenue Growth Rate in Oral Antihypertensive Drug Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Household Embroidery Machines Market Research Report 2025
Jul 18, 25
Global Residential Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Global Commercial Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232